Zynerba Pharmaceuticals Announces Pricing of Its Initial Public Offering

DEVON, Pa., Aug. 4, 2015 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc., announced today the pricing of its initial public offering of 3 million shares of common stock at a public offering price of $14.00 per share, before underwriting discounts. All of the shares in the offering are being sold by Zynerba. In addition, Zynerba has granted the underwriters an option to purchase up to 450,000 additional shares of common stock at the public offering price, less the underwriting discount. Zynerba’s common stock has been approved for listing on the NASDAQ Global Market and is expected to begin trading under the symbol “ZYNE” on August 5, 2015.

Click here to read the full press release.


©2016 PACT All Rights Reserved